Skip to main content
Year archive

Vita 34 AG — 2019 filings

All 37 regulatory filings released by Vita 34 AG (V3V) in 2019, sourced directly from the official regulator.

37 Filings
2019 Period
2019 filings (37)
Filing Released Lang
Articles of Association (in German) 2019
Governance Information
2019-12-11 German
Satzung 2019
Governance Information
2019-12-11 German
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-25 English
Sales growth in core markets further increases margins for Vita 34
Earnings Release Q3 2019
2019-11-21 English
Q3 statement / Q3 financial report 2019
Interim / Quarterly Report 9M 2019
2019-11-21 English
Report Publication Announcement 2019
Report Publication Announcement
2019-11-14 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2019 bis zum 30.09.2019
Report Publication Announcement
2019-11-14 German
Datum:14.11.2019
Report Publication Announcement
2019-11-14 German
Unternehmenspräsentation | November 2019
Investor Presentation
2019-11-01 German
Unternehmenspräsentation | September 2019
Investor Presentation
2019-09-01 English
Vita 34 closes first half-year 2019 with operating profit margins at record levels
Earnings Release H1 2019
2019-08-29 English
Datum:29.08.2019
Interim / Quarterly Report H1 2019
2019-08-29 German
Half-yearly financial report 2019
Interim / Quarterly Report H1 2019
2019-08-29 German
Report Publication Announcement 2019
Report Publication Announcement
2019-08-22 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2019 bis zum 30.06.2019
Report Publication Announcement
2019-08-22 German
Datum:22.08.2019
Report Publication Announcement
2019-08-22 German
Datum:15.07.2019
AGM Information
2019-07-15 German
Annual General Meeting of Vita 34 AG agrees in all agenda items with the administration
AGM Information
2019-06-05 English
Vita 34 significantly increases profitability in the first quarter and paves the way for expansion of the product portfolio
Earnings Release Q1 2019
2019-05-09 English
Q1 statement / Q1 financial report 2019
Interim / Quarterly Report Q1 2019
2019-05-09 English
Report Publication Announcement 2019
Report Publication Announcement
2019-05-08 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2019 bis zum 31.03.2019
Report Publication Announcement
2019-05-08 German
Datum:08.05.2019
Report Publication Announcement
2019-05-08 German
Datum:03.05.2019
Annual Report FY 2018
2019-05-03 German
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements
2019-04-23 English
Datum:15.04.2019
Annual Report FY 2018
2019-04-15 German
Unternehmenspräsentation | April 2019
Investor Presentation
2019-04-01 German
Vita 34 surpasses full-year guidance for 2018 at earnings level
Earnings Release FY 2018
2019-03-28 English
Annual financial report 2018
Annual Report FY 2018
2019-03-28 German
Declaration of Compliance 2019
Governance Information
2019-03-25 English
Entsprechenserklärung 2019
Governance Information
2019-03-25 German
Report Publication Announcement 2019
Report Publication Announcement
2019-03-21 English
Hinweis auf Jahresfinanzbericht vom 01.01.2018 bis zum 31.12.2018
Report Publication Announcement
2019-03-21 German
Datum:21.03.2019
Report Publication Announcement
2019-03-21 German
Vita 34 concludes 2018 with significant earnings growth according to preliminary figures
Earnings Release FY 2018
2019-02-28 English
Vita 34 develops cell preparations as the source material for immune cell therapies and becomes cell bank
Regulatory Filings
2019-02-08 English